Definitive Contract 75F40122C00181
- Not listed
- The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price definitive contract to Brigham & Women's Hospital Inc., a non-profit hospital and research institution in Boston, MA, to conduct a study titled "Risk Evaluation and Mitigation Strategy (REMS) Programs to Promote Appropriate Medication Use and Knowledge". The contract does not have a set-aside designation and has a potential value of $4,419,354.00. The completion date for this...
- The Department of Health and Human Services Food and Drug Administration awarded a $2,963,836.42 firm fixed price delivery order contract to Brigham & Women's Hospital Inc., a not-for-profit hospital and research institution in Boston, Massachusetts. The contract supports developing capability to use Medicaid data for FDA post-market drug safety surveillance during pregnancy. This contract is a task order under the FDA's Scientific Pharmacoepidemiologic Research Program, a larger...
- The Department of Health and Human Services Food and Drug Administration awarded a $2,082,291.00 firm fixed price definitive contract to Brigham & Women's Hospital Inc., a non-profit hospital and research institution in Boston, Massachusetts. The contract is for "Effectiveness Research with Real World Data to Support FDA's Regulatory Decision Making." It does not have a set-aside designation. Under the contract, Brigham & Women's Hospital is working closely with the FDA's...
- The Department of Health and Human Services Food and Drug Administration awarded a firm-fixed-price contract to Brigham & Women's Hospital Inc., a not-for-profit hospital and research institution in Boston, Massachusetts. The $120,000 contract is for services in support of a project entitled "Confidence in Decision-Making: Evaluating a Structured Reporting Template to Increase Transparency and Reduce Review Time for Healthcare Database Studies." The contract has a completion date...
- This is a $5,654,163.32 firm fixed price delivery order contract awarded by the Franchise Acquisition Services agency to Brigham & Women's Hospital Inc., a major academic medical center and research institution in Boston, Massachusetts. The contract is for research subjects and has an ultimate completion date of December 31, 2024. Brigham & Women's Hospital is a subsidiary of the larger Partners Healthcare System Incorporated, which has a history of federal contract and grant awards,...
- This federal contract award was issued by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to Brigham & Women's Hospital Inc., a subsidiary of the Partners Healthcare System, to conduct a "FOLLOW ONTO CLINICAL TRIAL". The cost-plus-award-fee contract has a ceiling value of $19,298,282.02 and an ultimate completion date of December 11, 2013. Brigham & Women's Hospital, as a major academic medical center and research institution, has a long history of...
- This is a $2,000,000.00 federal contract award to Brigham & Women's Hospital Inc., a nonprofit academic medical center in Boston, Massachusetts. The contract was awarded by the National Institutes of Health (NIH) to support the hospital's work on the ADAPT program, focused on developing early multimodal data fusion methods for integrating radiology, histopathology, and genomics. This is an Other Transaction Agreement (OTA) with a period of performance through May 19, 2028. Brigham &...
- This federal contract was awarded by the Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute to Brigham & Women's Hospital Inc., a not-for-profit hospital and research institution in Boston, Massachusetts. The contract, valued at $4,406,839.60, is a definitive cost-no-fee contract with a completion date of April 6, 2017. No set-aside designation was used. Brigham & Women's Hospital Inc. has provided research, data analytics, and...
- This is a firm-fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to Brigham & Women's Hospital Inc., a subsidiary of Partners Healthcare System Incorporated, for $377,173.48. The contract is for bioinformatics research support services to be performed in Boston, MA, with a period of performance through September 2024. Brigham & Women's Hospital Inc. is a prominent academic medical center and research institution with extensive capabilities in...
- This is a $1,673,605.00 definitive contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Brigham & Women's Hospital Inc., a major academic medical center and research institution located in Boston, Massachusetts. The contract is for unspecified "BIOMEDICAL (BASIC)" services and does not have a small business set-aside designation. Brigham & Women's Hospital is a subsidiary of the larger Partners...
The Food and Drug Administration (FDA) awarded a $4,691,150.00 firm fixed price contract to Brigham & Women's Hospital Inc. to conduct research on calibrating real-world evidence (RWE) studies in oncology against randomized clinical trials. The contract has a completion date of January 29, 2027 and does not have a small business set-aside designation. Brigham & Women's Hospital is a subsidiary of the larger Partners Healthcare System Incorporated, which is a major integrated healthcare system in Boston. Partners Healthcare and its subsidiaries have extensive experience conducting biomedical and clinical research across various specialties with support from federal contracts and grants. This contract aligns with the FDA's initiatives to leverage RWE to complement traditional randomized controlled trials for oncology product evaluations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Funding Only Action | $991.2k | 12/27/24 | |
| P00001 | Other Administrative Action | $0 | 1/11/23 | |
| Not listed | Not listed | $2.7m | 9/21/22 |